P&G Hygiene and Health Care logo

P&G Hygiene and Health Care

PGHH NSE

Key Fundamentals

SmallcapPersonal CareConsumer Goods
Market Cap
₹24,402 Cr
Volatility
Low Risk
P/E Ratio
30.86
EBITDA
₹1,214 Cr
Return on Equity
113.67%
Debt to Equity
0
Book Value
₹232.12
EPS
₹229.57
52W High
₹14,509
52W Low
₹7,562

Tapetide Score

Data-driven rating, 0–100. How it works →

Key Insights

Strengths

5
  • Company has reduced debt.
  • Company is almost debt free.
  • Stock is providing a good dividend yield of 3.06%.
  • Company has a good return on equity (ROE) track record: 3 Years ROE 89.3%
  • Company has been maintaining a healthy dividend payout of 91.5%

Weaknesses

2
  • Stock is trading at 32.4 times its book value
  • The company has delivered a poor sales growth of 7.40% over past five years.

Growth Rate

Revenue Growth
27% higher than 3Y
Net Income Growth
34.54% higher than 3Y
Cash Flow Change
54.48% lower than 3Y
ROE
31.59% lower than 3Y
ROCE
31.92% higher than 3Y
EBITDA Margin (Avg.)
5.18% lower than 3Y

AI Analysis — Bull vs Bear

Anthropic anthropic claude-opus-4.6 5d ago
AI opinion · based on fundamentals
Risk high

Procter & Gamble Hygiene and Health Care Ltd has a market cap of ₹24,768 Cr with an exceptionally high ROE of 115% (last year) and a near debt-free balance sheet. However, the stock has seen a sharp 42% decline over the past year, sales growth has turned negative at -2% TTM, and it trades at a steep 32.9x price-to-book ratio.

Bull Case 7
  • Exceptionally high return on equity with last year ROE at 115% and a 3-year average ROE of 89%, indicating highly efficient capital utilization
  • Company is almost debt-free, providing significant financial resilience and flexibility during economic downturns
  • Attractive dividend yield of 3.34% backed by a consistent dividend payout ratio of 91.5%, offering steady income to shareholders
  • Compounded profit growth of 14% over both 3-year and 5-year periods demonstrates sustained earnings expansion
  • Backed by global parent Procter & Gamble, providing access to strong R&D capabilities, established brands, and global best practices in the hygiene and health care segment
  • 10-year compounded sales growth of 6% and profit growth of 9% reflect a stable long-term business trajectory despite recent softness
  • Company has actively reduced debt, further strengthening an already clean balance sheet
Bear Case 8
  • Stock has declined 42% over the past 1 year and 24% CAGR decline over 3 years, reflecting significant and sustained erosion in market value
  • Trading at 32.9x book value is extremely elevated, leaving very limited margin of safety even for a high-quality franchise
  • TTM sales growth has turned negative at -2%, signaling potential demand weakness or market share pressure in core categories
  • TTM profit growth is also negative at -5%, indicating that earnings momentum has reversed after years of expansion
  • 5-year compounded sales growth of only 7.4% is modest for a consumer goods company in a high-growth market like India
  • PE ratio of 31.4x is demanding given the current negative sales and profit growth trajectory on a trailing basis
  • 10-year stock CAGR of just 2% suggests the stock has delivered negligible long-term capital appreciation for investors over the past decade
  • 5-year stock CAGR of -12% indicates persistent de-rating or earnings disappointment over a medium-term horizon

This is AI-generated analysis, not financial advice. Do your own due diligence.

AI News Digest

Anthropic anthropic claude-opus-4.6 2h ago
Positives 2
  • FY26 profit surges 35% Aug 17

    P&G Hygiene reported a 35% jump in net profit to ₹857 crore on revenue of ₹4,290 crore for FY26, declaring a total dividend of ₹255 per share.

  • ₹86 crore productivity savings Sep 8

    At the AGM, management highlighted ₹86 crore in productivity savings and a 19% PAT rise despite flat sales, underscoring margin-led growth and an integrated growth strategy.

Neutral 1
  • FY26 BRSR report filed Aug 17

    P&G Hygiene submitted its FY26 Business Responsibility & Sustainability Report, noting CSR outreach to 1 crore children and zero Scope 2 emissions.

TL;DR: P&G Hygiene delivered strong profit growth of 35% in FY26 driven by cost efficiencies and productivity savings of ₹86 crore, even as top-line growth remained flat. The generous ₹255 per share dividend signals management confidence in cash flows. The key risk to watch is the lack of revenue growth, which suggests volume or pricing headwinds in the consumer goods segment. If the company can convert its margin discipline into sustained top-line momentum, the trend could turn decisively bullish.

Quarterly Results

Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
853
1,138
1,133
1,002
932
1,135
1,248
992
937
1,150
1,262
941
891
Expenses
638
853
824
745
813
845
877
782
671
865
860
723
721
Operating Profit
215
285
310
257
118
290
371
210
266
285
402
218
170
OPM %
25%
25%
27%
26%
13%
26%
30%
21%
28%
25%
32%
23%
19%
Other Income
10
16
16
14
7
8
10
19
8
10
12
12
9
Interest
3
2
3
22
0
2
7
6
0
4
3
3
0
Depreciation
15
14
14
15
13
12
10
10
9
9
10
10
10
PBT
207
284
309
234
112
285
364
213
265
282
402
218
170
Tax %
27%
26%
26%
34%
28%
26%
26%
27%
27%
26%
25%
30%
26%
Net Profit
151
211
229
154
81
212
269
156
192
210
301
153
126
EPS in Rs
46.59
64.91
70.52
47.56
24.97
65.28
82.74
48.09
59.17
64.65
92.87
47.17
38.9
Figures in ₹ Crores

Profit & Loss

Particulars Jun 2015Jun 2016Jun 2017Jun 2018Jun 2019Jun 2020Jun 2021Jun 2022Jun 2023Jun 2024Mar 2025Mar 2026TTM
Sales
2,334
2,275
2,320
2,455
2,947
3,002
3,574
3,901
3,918
4,206
3,374
4,290
4,245
Expenses
1,838
1,667
1,646
1,834
2,329
2,396
2,688
3,069
3,048
3,230
2,503
3,119
3,170
Operating Profit
495
608
675
622
618
606
886
832
869
976
871
1,171
1,075
OPM %
21%
27%
29%
25%
21%
20%
25%
21%
22%
23%
26%
27%
25%
Other Income
64
85
67
18
45
42
38
23
40
47
37
42
44
Interest
6
6
10
5
5
6
6
11
11
27
14
9
10
Depreciation
53
52
60
52
50
48
48
53
58
56
32
37
38
PBT
501
636
672
582
607
594
870
790
839
939
862
1,167
1,072
Tax %
31%
34%
36%
36%
31%
27%
25%
27%
19%
28%
26%
27%
—
Net Profit
346
422
433
375
419
433
652
576
678
675
637
856
791
EPS in Rs
107
130
133
115
129
133
201
177
209
208
196
264
244
Div. Payout %
28%
28%
292%
35%
68%
79%
157%
90%
89%
123%
89%
97%
—
Figures in ₹ Crores

Balance Sheet

Particulars Jun 2015Jun 2016Jun 2017Jun 2018Jun 2019Jun 2020Jun 2021Jun 2022Jun 2023Jun 2024Mar 2025Mar 2026
Equity Capital
32
32
32
32
32
32
32
32
32
32
32
32
Reserves
1,196
1,619
494
773
877
1,125
682
705
914
742
705
721
Borrowings
0
0
0
0
0
0
3
5
4
3
2
1
Other Liabilities
719
515
634
620
708
671
915
940
1,187
1,081
1,015
1,049
Total Liabilities
1,948
2,166
1,160
1,425
1,617
1,828
1,633
1,683
2,137
1,859
1,755
1,804
Fixed Assets
309
317
286
250
234
206
184
164
170
139
131
163
CWIP
39
35
41
21
15
22
38
44
23
28
41
21
Investments
0
0
0
0
0
0
0
0
0
0
0
0
Other Assets
1,600
1,814
834
1,154
1,368
1,600
1,411
1,475
1,945
1,692
1,583
1,619
Total Assets
1,948
2,166
1,160
1,425
1,617
1,828
1,633
1,683
2,137
1,859
1,755
1,804
Figures in ₹ Crores

Cash Flow

Particulars Jun 2015Jun 2016Jun 2017Jun 2018Jun 2019Jun 2020Jun 2021Jun 2022Jun 2023Jun 2024Mar 2025Mar 2026
Operating
426
352
445
415
413
474
863
573
826
470
598
924
Investing
28
221
149
-19
34
75
7
-27
-10
1
-34
11
Financing
-105
-122
-1,559
-106
-314
-190
-1,106
-569
-477
-861
-671
-845
Net Cash Flow
349
452
-964
290
134
358
-236
-23
339
-390
-107
91
Free Cash Flow
348
300
401
377
410
423
832
523
781
427
544
893
CFO/OP
127
91
103
111
105
102
126
99
121
79
96
105
Figures in ₹ Crores

Ratios

Particulars Jun 2015Jun 2016Jun 2017Jun 2018Jun 2019Jun 2020Jun 2021Jun 2022Jun 2023Jun 2024Mar 2025Mar 2026
Debtor Days
18
24
21
22
22
20
15
18
20
21
33
21
Inventory Days
47
53
71
48
60
68
78
55
48
51
64
51
Days Payable
148
134
145
156
162
175
237
183
213
193
235
197
Cash Conversion Cycle
-83
-57
-53
-87
-79
-87
-144
-110
-145
-121
-138
-126
Working Capital Days
4
8
-15
-23
-12
-21
-39
-34
-53
-32
-30
-31
ROCE %
46%
45%
64%
89%
73%
58%
94%
110%
101%
112%
104%
157%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view P&G Hygiene and Health Care insights

62 extracted metrics + investor summaries across FY10–FY26.

Log in — free

Shareholding Pattern

FIIs0.98%Promot.70.64%Others2.76%Public10.04%DIIs15.59%As ofJun 2026

Documents

Frequently Asked Questions about P&G Hygiene and Health Care

What does Procter & Gamble Hygiene and Health Care Ltd do?
Procter & Gamble Hygiene and Health Care Limited is engaged in the manufacturing and selling of branded packaged fast moving consumer goods in the femcare and healthcare businesses. Its portfolio includes WHISPER – India’s leading Feminine Hygiene brand, and VICKS – India’s No. 1 Health Care bran...
Where is Procter & Gamble Hygiene and Health Care Ltd (PGHH) listed?
Procter & Gamble Hygiene and Health Care Ltd trades as PGHH on the NSE and under code 500459 on the BSE.
Which sector does Procter & Gamble Hygiene and Health Care Ltd belong to?
Procter & Gamble Hygiene and Health Care Ltd is classified under the Consumer Goods sector, in the Personal Care industry.
What is the market capitalisation of Procter & Gamble Hygiene and Health Care Ltd?
Procter & Gamble Hygiene and Health Care Ltd has a market capitalisation of ₹24,402 Cr, which places it in the Large Cap band.
What is the PE ratio of Procter & Gamble Hygiene and Health Care Ltd?
Procter & Gamble Hygiene and Health Care Ltd trades at a PE ratio of 30.86, on earnings per share of ₹229.57, against a book value of ₹232.12 per share.
What is the 52-week high and low of Procter & Gamble Hygiene and Health Care Ltd?
Over the last 52 weeks Procter & Gamble Hygiene and Health Care Ltd has traded between ₹7,562 and ₹14,509.
Does Procter & Gamble Hygiene and Health Care Ltd pay dividends?
Procter & Gamble Hygiene and Health Care Ltd has a dividend yield of 3.36%.
What is the Return on Equity (ROE) of Procter & Gamble Hygiene and Health Care Ltd?
Procter & Gamble Hygiene and Health Care Ltd reported a return on equity of 113.67%. Its debt-to-equity ratio is 0.00.

Company Information

Procter & Gamble Hygiene and Health Care Limited is engaged in the manufacturing and selling of branded packaged fast moving consumer goods in the femcare and healthcare businesses. Its portfolio includes WHISPER – India’s leading Feminine Hygiene brand, and VICKS – India’s No. 1 Health Care brand and Old Spice.

Website pg.com/en_IN
Listed 2004-07-07
Face Value ₹ 10
Issued Size 3,24,60,736

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/PGHH.md for Procter & Gamble Hygiene and Health Care Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our MCP server.

Explore More

More in Consumer Goods → FII DII Data Stock Screener Nifty 50 Heatmap F&O Ban List